Concepedia

Publication | Open Access

Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation

113

Citations

40

References

2021

Year

Abstract

Thus, we developed a therapeutic strategy for COVID-19 based on inhalation of a modified siRNA-peptide dendrimer formulation. The developed medication is intended for inhalation treatment of COVID-19 patients.

References

YearCitations

Page 1